Tsfg, LLC Edwards Lifesciences Corp Transaction History

Tsfg, LLC

$428 Million
Q2 2024

A detailed history of Tsfg, LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Tsfg, LLC holds 87,859 shares of EW stock, worth $5.85 Million. This represents 1.9% of its overall portfolio holdings.

Number of Shares

87,859

Previous 80,989 8.48%

Holding current value

$5.85 Million

Previous $7.74 Million 4.87%

% of portfolio

1.9%

Previous 1.95%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 16, 2024	BUY	$84.3 - $94.31 $579,141 - $647,909	6,870 Added 8.48%	87,859 $8.12 Million
Q1 2024 Apr 16, 2024	SELL	$72.54 - $95.56 $287,185 - $378,322	-3,959 Reduced 4.66%	80,989 $7.74 Million
Q4 2023 Jan 23, 2024	SELL	$61.71 - $77.76 $38,568 - $48,600	-625 Reduced 0.73%	84,948 $6.48 Million
Q3 2023 Oct 10, 2023	SELL	$69.28 - $93.38 $2,632 - $3,548	-38 Reduced 0.04%	85,573 $5.93 Million
Q2 2023 Jul 10, 2023	SELL	$81.41 - $94.33 $183,905 - $213,091	-2,259 Reduced 2.57%	85,611 $8.08 Million
Q1 2023 Apr 21, 2023	BUY	$74.26 - $84.51 $74,854 - $85,186	1,008 Added 1.16%	87,870 $7.27 Million
Q4 2022 Jan 19, 2023	BUY	$68.3 - $87.44 $65,294 - $83,592	956 Added 1.11%	86,862 $6.48 Million
Q3 2022 Oct 20, 2022	BUY	$82.37 - $107.29 $139,452 - $181,641	1,693 Added 2.01%	85,906 $7.1 Million
Q2 2022 Jul 13, 2022	SELL	$86.5 - $128.27 $8,650 - $12,827	-100 Reduced 0.12%	84,213 $8.01 Million
Q1 2022 Apr 25, 2022	SELL	$101.96 - $128.34 $28,344 - $35,678	-278 Reduced 0.33%	84,313 $9.93 Million
Q4 2021 Feb 10, 2022	BUY	$106.37 - $130.68 $145,195 - $178,378	1,365 Added 1.64%	84,591 $11 Million
Q3 2021 Oct 12, 2021	BUY	$102.91 - $122.75 $50,220 - $59,902	488 Added 0.59%	83,226 $9.42 Million
Q2 2021 Jul 19, 2021	SELL	$83.84 - $104.76 $19,283 - $24,094	-230 Reduced 0.28%	82,738 $8.57 Million
Q1 2021 Apr 14, 2021	SELL	$78.68 - $90.67 $40,048 - $46,151	-509 Reduced 0.61%	82,968 $6.94 Million
Q4 2020 Jan 20, 2021	SELL	$71.69 - $91.23 $7,384 - $9,396	-103 Reduced 0.12%	83,477 $7.62 Million
Q3 2020 Oct 06, 2020	SELL	$67.19 - $87.44 $19,821 - $25,794	-295 Reduced 0.35%	83,580 $6.67 Million
Q2 2020 Jul 07, 2020	BUY	$57.54 - $76.95 $3.22 Million - $4.31 Million	56,027 Added 201.19%	83,875 $5.8 Million
Q1 2020 Apr 08, 2020	SELL	$52.41 - $81.0 $15,513 - $23,976	-296 Reduced 1.05%	27,848 $5.25 Million
Q4 2019 Jan 27, 2020	SELL	$71.7 - $82.09 $16,491 - $18,880	-230 Reduced 0.81%	28,144 $6.57 Million
Q3 2019 Jan 27, 2020	SELL	$61.55 - $75.43 $47,639 - $58,382	-774 Reduced 2.66%	28,374 $6.24 Million
Q2 2019 Jan 27, 2020	BUY	$55.74 - $64.41 $69,897 - $80,770	1,254 Added 4.5%	29,148 $5.39 Million
Q1 2019 Jan 27, 2020	BUY	$47.89 - $64.05 $1.34 Million - $1.79 Million	27,894 New	27,894 $5.34 Million

Others Institutions Holding EW

# of Institutions

1,417

Shares Held

470M

Call Options Held

2.44M

Put Options Held

2.65M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $41.2B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tsfg, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tsfg, LLC with notifications on news.

Account